A role for biogenic amines in developmental language disorders.
The authors discuss the current uncertainty regarding etiology, treatment, and classification of developmental language disorders (DLD). Referring to previous reports in the literature, they propose a specific subclass of DLD associated with a hypothesized dysfunction of the dopaminergic system of the basal ganglia. Mechanisms of dysfunction and treatment implications are discussed.
Kerbeshian
J
J
Department of Neuroscience, University of North Dakota School of Medicine, Grand Forks 58202.
Gascon
G
G
Burd
L
L
D001479:Basal Ganglia / Q000378:metabolism / Q000503:physiopathology; D001679:Biogenic Amines / Q000378:metabolism / Q000502:physiology*; D002648:Child; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D007806:Language Disorders / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged
D001679:Biogenic Amines; D006220:Haloperidol